Market research reports on: Pharmaceutical manufacture, cancer, oncology, prevention and treatment, therapeutics, vaccines, clinical studies, drug delivery, immunology, immunotherapy and others.Get a Free Trial
243 Reports in Pharmaceuticals
The global market for Alzheimer's disease treatment should grow from $4.8 billion in 2020 to $6.3 billion by 2025 with a compound annual growth rate (CAGR) of 5.5% during the period of 2020-2025.
The global market for autoimmune disorder therapies should grow from $53.2 billion in 2019 to $90.7 billion by 2024 with a compound annual growth rate (CAGR) of 11.2% for the period of 2019-2024.
This report provides an overview of the current and future market dynamics of the peanut allergy treatment market. The study explores the management of peanut allergy, epidemiology, economic burden, and includes an overview of a new peanut allergen treatment, Palforzia.
This report provides an overview of the idiopathic pulmonary fibrosis (IPF). It outlines perspective on the drugs and therapies used for the management of IPF, including forecast trends and sales through 2024. Important manufacturers, technologies and factors influencing demand are discussed.
The global market for sexually transmitted disease diagnostics should grow from $7.6 billion in 2020 to $10.6 billion by 2025 at compound annual growth rate (CAGR) of 7.0% for the period of 2020-2025.
The goals of this study were to understand the current market scenario for the treatment options of phenylketonuria (PKU) which includes food for medical purposes (FSMPs), and to assess the market’s growth potential through the end of 2025. This study explores market dynamics such as drivers, restraints, opportunities, and trends that impact the growth of the market. The main objective of the study is to present a comprehensive analysis of the current treatment market for phenylketonuria and the future directions of the market.
The global acne drugs market should reach $7.9 billion by 2025 from $5.9 billion in 2020 at a compound annual growth rate (CAGR) of 5.7% for the forecast years, 2020 to 2025.
The global outsourcing services market for drug and medical device development is expected to grow from 130.5 billion pounds in 2020 to 205.6 billion pounds by 2025 with a compound annual growth rate (CAGR) of 9.5% for the period of 2020-2025.
The global market for cannabidiol (CBD) oil should grow from $967.2 million in 2020 to $5.3 billion by 2025, at compound annual growth rate (CAGR) of 40.4% for the period of 2020-2025.
The global market for vaccine technologies totaled $40.1 billion in 2019. The market should grow from $42.6 billion in 2020 to $57.8 billion by 2025, at a compound annual growth rate (CAGR) of 6.3% during the 2020-2025 forecast period.
CDMO is an evolving industry with abundant growth opportunities for service providers. CDMO industry is trending towards consolidation; thus, CDMO companies are evolving as integrated pharmaceutical service providers or one-stop solution providers. This report provides details on the CDMO industry including the future trends and latest developments.
The global market for women’s health therapeutics should grow from $31.5 billion in 2019 to $41.2 billion by 2025, at a compound annual growth rate (CAGR) of 4.7% for the period of 2019-2025.
The global pharmaceuticals market was valued at $1,058 billion in 2019 and should reach $1,520 billion by 2024 with a compound annual growth rate (CAGR) of 7.5% from 2019 to 2024.
The global rare disease diagnostics market should reach $26.7 billion by 2024 from $17 billion in 2019 at a compound annual growth rate (CAGR) of 9.5% for the forecast period of 2019 to 2024.
The global market for pain management patches should grow from $4.2 billion in 2018 to $5.3 billion by 2023, at a compound annual growth rate (CAGR) of 4.5% for the period of 2018-2023.
This report focuses on epidemiology, research and development, current treatment and diagnostics and global response to selected pandemics of the past decade (2009-2020). The report discusses lessons learned from previous outbreaks in terms of policies and measures of prevention and control.
The global market for antifungal drugs should grow from $14.6 billion in 2019 to reach $17.6 billion by 2024, at a compound annual growth rate (CAGR) of 3.8% for the forecast period of 2019-2024.
The goal of this study is to provide information on the global health technology approval process in North America, Europe and the Asia-Pacific region. The study emphasizes the role of HTA and its function and technology process in the pharmaceutical industry. The report also elaborates on recent HTA approvals and their significance on pricing and reimbursement.
According to the National Science Foundation (NSF) the term nano refers to particles, structures, or devices having at least one dimension below 100 nm. Development, manufacturing and sale of these products have spawned a multibillion industry, commonly referred to as the nanotechnology sector. This report gives a market outlook of nanotechnology in cancer treatment and provides information on its most relevant applications. The major trends, issues and recent achievements in nanotechnology-based cancer treatment are also discussed.
The hyperkalemia market is currently a flourishing market, with a strong drug pipeline and upcoming technologies for the diagnosis of conditions. This report on Hyperkalemia Market highlights market dynamics such as drivers, restraints, opportunities and trends that impact the growth of the market. BCC Research focuses on the comprehensive analysis of the current market for hyperkalemia and the future direction of the market.
This report on Medical Affairs highlights overall growth due to rapidly changing pharmaceutical and medical device markets by forming new paradigms and employing marketing strategies that increase market share. The research will provide information on leading market competitors, their market share, partnerships, collaborations, mergers and acquisitions between pharmaceutical companies. BCC Research focuses on the importance of medical affairs in communicating and collecting the medical evidence with the organization and external stakeholders.
The goal of this short study is to help companies operating within the life science sector gain valuable insights on bioinks by providing an overview of types, compositions, and applications of bioinks. This report outlines the trends that are expected to contribute to market growth for these materials.
This comprehensive report provides an in-depth assessment of the global market for non-injectable insulin. The report's key objective is to analyze areas of opportunities, key developments and the impact of this technology on industry, specifically the pharmaceutical, biotechnology and healthcare sectors. The analysis also reviews the adoption of non-injectable insulin in developed and emerging markets.
In the context of the huge impact of generic drug development and its implication in cost savings, an attempt has been made to analyze various pharmaceutical original products which experience patent expiry and likely to go off patents. The report also covers a section illustrating the case for development and opportunities that lie for manufacturers engaged in the generic or biosimilar business for the key drugs.
This report is designed to investigate recent years of performance of pharmaceutical and biopharmaceutical companies with respect to return on investment (ROI) in research and development (R&D), and to discuss ways that companies are trying to improve ROI through 2024. Investigation will include Country/Regional market trends with top areas of return, 2014-2024. This report also looks at which companies are already using artificial intelligence (AI) and machine learning (ML) to successfully compete globally.
4 Upcoming Reports in Pharmaceuticals
This report provides an overview of the global market for flexible manufacturing systems in pharmaceutical industry, market share analysis based on approaches, industry type, application, and geography.
This report provides an overview of the global market for targeted therapeutics, analyses of global market trends, with data from 2020, estimates for 2021 and projections of compound annual growth rates (CAGRs) through 2026.
This report provides an updated review of the current and future potential for the global markets for antifungal drugs along with highlights of key market dynamics, regulatory scenario, and COVID-19 impact on the progress of this market.
This report provides an updated review of the global market for vaccine technologies, with data from 2019-2020, estimates for 2021, and projections of compound annual growth rates (CAGRs) through 2026.